{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:47:31Z","timestamp":1791586051549,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015807","name":"Hangzhou Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003786","name":"Hangzhou Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003786","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.canlet.2026.218356","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:54:01Z","timestamp":1771865641000},"page":"218356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Patient-derived malignant effusion organoids guide tailored therapy and dissect third-generation EGFR-tyrosine kinase inhibitor resistance mechanisms in lung cancer"],"prefix":"10.1016","volume":"645","author":[{"given":"Yidan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9455-3296","authenticated-orcid":false,"given":"Huayang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2671-8015","authenticated-orcid":false,"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0205-1525","authenticated-orcid":false,"given":"Wangyue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingliang","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9178-5493","authenticated-orcid":false,"given":"Bing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2299-6876","authenticated-orcid":false,"given":"Xueqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canlet.2026.218356_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"7957","key":"10.1016\/j.canlet.2026.218356_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/d41586-023-00934-0","article-title":"Molecular portraits of lung cancer evolution","volume":"616","author":"Hayes","year":"2023","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.canlet.2026.218356_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41571-024-00971-2","article-title":"The changing treatment landscape of EGFR-mutant non-small-cell lung cancer","volume":"22","author":"Zhou","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218356_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100076","article-title":"Cracking the EGFR code: cancer biology, resistance mechanisms, and future therapeutic frontiers","volume":"77","author":"Du","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.canlet.2026.218356_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101266","article-title":"Molecular mechanisms of acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer","volume":"82","author":"Du","year":"2025","journal-title":"Drug Resist. Updates"},{"issue":"10","key":"10.1016\/j.canlet.2026.218356_bib6","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1039\/D4MD00384E","article-title":"Next-generation EGFR tyrosine kinase inhibitors to overcome C797S mutation in non-small cell lung cancer (2019-2024)","volume":"15","author":"Das","year":"2024","journal-title":"RSC Med. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2026.218356_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41571-025-01085-z","article-title":"Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC \u2014 mechanisms and evolving treatment approaches","volume":"23","author":"Zhao","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218356_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15061604","article-title":"The resistance to EGFR-TKIs in non-small cell lung cancer: from molecular mechanisms to clinical application of new therapeutic strategies","volume":"15","author":"Laface","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.canlet.2026.218356_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105007","article-title":"Lymecycline reverses acquired EGFR-TKI resistance in non-small-cell lung cancer by targeting GRB2","volume":"159","author":"Chen","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"12","key":"10.1016\/j.canlet.2026.218356_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122987","article-title":"Targeting HSF1 as a therapeutic strategy for multiple mechanisms of EGFR inhibitor resistance in EGFR mutant non-small-cell lung cancer","volume":"13","author":"Lee","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.canlet.2026.218356_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011733","article-title":"Tumor organoids in immunotherapy: from disease modeling to translational research","volume":"13","author":"Si","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"21","key":"10.1016\/j.canlet.2026.218356_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302331","article-title":"Patient-derived organoids as therapy screening platforms in cancer patients","volume":"13","author":"Khorsandi","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"1","key":"10.1016\/j.canlet.2026.218356_bib13","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1038\/s41467-019-11867-6","article-title":"Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening","volume":"10","author":"Kim","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2026.218356_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-026-00743-x","article-title":"Organoids for disease modeling and treatment: state-of-the-art","volume":"15","author":"Xu","year":"2026","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218356_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12931-024-02684-7","article-title":"Malignant pleural effusion: current understanding and therapeutic approach","volume":"25","author":"Gonnelli","year":"2024","journal-title":"Respir. Res."},{"issue":"2","key":"10.1016\/j.canlet.2026.218356_bib16","article-title":"Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: a real-world study","volume":"4","author":"Wang","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218356_bib17","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1038\/s41598-020-59656-2","article-title":"Assessment of modelling strategies for drug response prediction in cell lines and xenografts","volume":"10","author":"Kurilov","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.canlet.2026.218356_bib18","article-title":"Oncogenic role of RARG rearrangements in acute myeloid leukemia resembling acute promyelocytic leukemia","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2026.218356_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41698-024-00609-7","article-title":"Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusion","volume":"8","author":"Lee","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.canlet.2026.218356_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104285","article-title":"A systematic review of patient-derived tumor organoids generation from malignant effusions","volume":"195","author":"Seghers","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218356_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/cancers17010027","article-title":"A two-step protocol for isolation and maintenance of lung cancer primary 3D cultures","volume":"17","author":"Strocchi","year":"2024","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.canlet.2026.218356_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41563-021-01057-5","article-title":"Next-generation cancer organoids","volume":"21","author":"LeSavage","year":"2022","journal-title":"Nat. Mater."},{"issue":"10","key":"10.1016\/j.canlet.2026.218356_bib23","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1038\/s41596-020-0379-4","article-title":"Establishment of patient-derived cancer organoids for drug-screening applications","volume":"15","author":"Driehuis","year":"2020","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.canlet.2026.218356_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s13402-025-01158-2","article-title":"Optimized patient-derived lung cancer organoids recapitulating the immune landscape for precision therapy evaluation","volume":"49","author":"Xing","year":"2026","journal-title":"Cell. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218356_bib25","article-title":"Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: a real-world study","volume":"4","author":"Wang","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218356_bib26","article-title":"Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer","volume":"6","author":"Gu","year":"2025","journal-title":"Molecul. Biomed."},{"issue":"1","key":"10.1016\/j.canlet.2026.218356_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/biomethods\/bpaf012","article-title":"Optimizing drug sensitivity assays in patient-derived tumor organoids: a comparison of IC50 estimation methods and experimental parameters","volume":"10","author":"Chen","year":"2025","journal-title":"Biol. Meth. Protocol."},{"issue":"18","key":"10.1016\/j.canlet.2026.218356_bib28","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1158\/1078-0432.CCR-22-1912","article-title":"Tackling osimertinib resistance in EGFR-mutant non-small cell lung cancer","volume":"29","author":"Blaquier","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.canlet.2026.218356_bib29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jtho.2024.11.027","article-title":"Receptor tyrosine kinase fusion-mediated resistance to EGFR TKI in EGFR-mutant NSCLC: a multi-center analysis and literature review","volume":"20","author":"Xia","year":"2025","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218356_bib30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/03602532.2021.1903488","article-title":"Ibuprofen-based advanced therapeutics: breaking the inflammatory link in cancer, neurodegeneration, and diseases","volume":"53","author":"Upadhyay","year":"2021","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.canlet.2026.218356_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.550","article-title":"Ibuprofen enhances the anticancer activity of cisplatin in lung cancer cells by inhibiting the heat shock protein 70","volume":"5","author":"Endo","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218356_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101571","article-title":"EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis","volume":"34","author":"Fan","year":"2020","journal-title":"Redox Biol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:10:13Z","timestamp":1777551013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526001199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":32,"alternative-id":["S0304383526001199"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218356","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-derived malignant effusion organoids guide tailored therapy and dissect third-generation EGFR-tyrosine kinase inhibitor resistance mechanisms in lung cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218356"}}